HSP990

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Advanced Solid MalignanciesAdvanced Solid Tumors

Phase 1

A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors

CompletedNCT00879905

Novartis PharmaceuticalsAdvanced Solid Malignancies

Start: 2009-05-31End: 2012-07-31Updated: 2020-12-08

Dose Escalation of HSP990 in Japan/Korea

TerminatedNCT01064089

Novartis PharmaceuticalsAdvanced Solid Tumors

Start: 2010-02-28End: 2012-01-31Updated: 2020-12-08